EN
HI
Windlas Biotech Chart
Windlas Biotech Share Key Metrics
Volume
25044.00
Market Cap
1700.85 CR
LTQ@LTP
65@805.85
ATP
805.09
Var Margin
19.79 %
Circuit Range
649.85-974.75
Delivery %
77.43 %
Value
2.02 CR
ASM/GSM
No
Market Lot
1
Summary
Windlas Biotech share price is ₹805.85 as of 3 Jun, 2026. The stock Windlas Biotech intraday movement has stayed between ₹798.20 and ₹819.45, while on a 52-week basis,Windlas Biotech price 52 week high is ₹1097.90 & its 52 week low is ₹697.40.
In terms of trading activity, Windlas Biotech has recorded a volume of 25044 shares, The Windlas Biotech has a market cap of ₹21106229 CR. The stock’s Average Traded Price (ATP) stands at ₹805.09, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 65 @ ₹805.85.
Windlas Biotech operates within a circuit range of ₹649.85 – ₹974.75, with a Value of ₹2.02 CR. The Delivery Percentage for the day is 77.43%. Additionally, Windlas Biotech currently falls under the No framework, and trades with a market lot size of 1.
Windlas Biotech Fundamentals
View MoreP/E Ratio
25.19
P/B Ratio
3.14
Div. Yield
0.78
Sector P/E
69.69
Sector P/B
2.97
Sec. Div. Yield
0.55
Windlas Biotech Resistance and Support
Pivot 812.8
Resistance
First Resistance
828.45
Second Resistance
844.6
Third Resistance
860.25
Support
First Support
796.65
Second Support
781
Third Support
764.85
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Windlas Biotech News
Windlas Biotech Ltd - 543329 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Recording Of Conference Call
Windlas Biotech informed that the audio recording of its Investors/Analyst conference call, held on May 18, 2026, for Q4 FY26 financial results, is now available on its website. The transcript will be shared with exchanges and uploaded in due course.
May 22 2026 16:33:33
Windlas Biotech Limited
Windlas Biotech's board has recommended a final dividend of Rs.6.3 per equity share at its meeting on May 21, 2026. This recommendation is subject to shareholder approval at the upcoming Annual General Meeting.
May 21 2026 17:44:58
Read More
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Shalby Ltd.
176.21
-0.63 (0.36%)
Venus Remedies Ltd.
1481.80
70.50 (5.00%)
Krsnaa Diagnostics Ltd.
541.00
-3.70 (0.68%)
Hester Biosciences Ltd.
1956.90
-58.50 (2.90%)
NGL Fine-Chem Ltd.
2645.10
-9.40 (0.35%)
Amrutanjan Health Care Ltd.
546.55
-9.30 (1.67%)
Beta Drugs Ltd.
1454.00
37.90 (2.68%)
Suraksha Diagnostic Ltd.
291.25
1.00 (0.34%)
Jagsonpal Pharmaceuticals Ltd.
201.99
0.25 (0.12%)
Ind-Swift Laboratories Ltd.
157.11
-4.99 (3.08%)
Windlas Biotech FAQs
The Buying Price of Windlas Biotech share is 805.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Windlas Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Windlas Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Windlas Biotech shares is 25.19. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Windlas Biotech shares is 3.14. Useful to assess the stock's value relative to its book value.
To assess Windlas Biotech’s valuation compare Sector P/E, P/B which are 69.69 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Windlas Biotech is 1700.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Windlas Biotech share price is 1097.90 & 697.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Windlas Biotech belongs to the Healthcare sector.
